首页 › 基金 › MMCAP International Inc. SPC › DMII
MMCAP International Inc. SPC 对 DMII 的持仓历史
DRUGS MADE IN AMER ACQ II CO · 金融
MMCAP International Inc. SPC 在 Q3 2026 的 13F 申报中披露持有 DMII(DRUGS MADE IN AMER ACQ II CO)2,700,000 股,市值约 US$27.5M,约占其申报组合的 1.96%,在其申报持仓中市值排名第 4 位。 MMCAP International Inc. SPC 最近 3 个申报季度中有 3 个季度披露了 DMII 持仓,最早可追溯至 Q1 2026。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
MMCAP International Inc. SPC 对 DMII 的持仓演变
MMCAP International Inc. SPC 于 Q1 2026 首次披露 DMII 持仓:2,700,000 股(约 US$26.9M)。 该持仓在 Q3 2026 达到峰值 2,700,000 股,市值约 US$27.5M。 在 3 次申报中,MMCAP International Inc. SPC 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 2,700,000 股、市值约 US$27.5M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2026 | 2.70M | $26.92M | 新进 |
| Q2 2026 | 2.70M | $27.16M | 持有 |
| Q3 2026 | 2.70M | $27.49M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 DMII 与 13F 数据
DMII(DRUGS MADE IN AMER ACQ II CO)属于金融行业。我们追踪的基金中还有 71 只申报持有 DMII,申报仓位最大的包括:Karpus Management, Inc. (US$28.0M), Magnetar Financial LLC (US$27.5M), GLAZER CAPITAL, LLC (US$23.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 DMII 的基金
- Karpus Management, Inc. 2.79M 股 · $28.05M · Q2 2026
- Magnetar Financial LLC 2.70M 股 · $27.51M · Q3 2026
- GLAZER CAPITAL, LLC 2.34M 股 · $23.57M · Q2 2026
- HIGHBRIDGE CAPITAL MANAGEMENT LLC 2.24M 股 · $22.57M · Q2 2026
- WOLVERINE ASSET MANAGEMENT LLC 1.84M 股 · $18.75M · Q3 2026
- First Trust Capital Management L.P. 1.30M 股 · $13.22M · Q3 2026
- Crossingbridge Advisors, LLC 1.10M 股 · $11.20M · Q3 2026
- Mercuria Capital Strategies, LLC 750.00K 股 · $7.63M · Q3 2026
- HEIGHTS CAPITAL MANAGEMENT, INC 519.40K 股 · $5.23M · Q2 2026
- TIG Advisors, LLC 500.00K 股 · $5.03M · Q2 2026
- Wealthspring Capital LLC 399.15K 股 · $4.06M · Q3 2026
- Logan Stone Capital, LLC 381.69K 股 · $3.84M · Q2 2026
更多关于 MMCAP International Inc. SPC
常见问题
How long has MMCAP International Inc. SPC held DMII?
MMCAP International Inc. SPC has disclosed DMII holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is MMCAP International Inc. SPC's current position in DMII?
As of Q3 2026, MMCAP International Inc. SPC holds 2.70M shares of DMII (DRUGS MADE IN AMER ACQ II CO), valued at $27.49M, representing 1.96% of its reported portfolio and ranking #4.
Has MMCAP International Inc. SPC been buying or selling DMII?
In the latest 13F filing (Q3 2026), MMCAP International Inc. SPC held unchanged its position in DMII. The position peaked in Q3 2026 at 2.70M shares.
Which other funds hold DMII?
Other major institutional holders of DMII include Karpus Management, Inc., Magnetar Financial LLC, GLAZER CAPITAL, LLC, among 71 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.